Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2001-2-22
pubmed:abstractText
To study the population pharmacokinetics of thioTEPA and its main metabolite TEPA in patients receiving high-dose chemotherapy consisting of thioTEPA (80-120 mg x m(-2) x day(-1)), cyclophosphamide (1000-1500 mg x m(-2) x day(-1)) and carboplatin (265-400 mg x m(-2) x day(-1)) for 4 days.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-10051062, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-10493531, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-1244564, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-1525606, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-1634926, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-1688514, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-1705489, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-1707751, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-1710167, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-1933869, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-2105156, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-2424593, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-2491958, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-2504483, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-3105905, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-3111687, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-3119200, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-3121202, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-3134519, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-3135933, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-3139316, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-6086064, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-7497586, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-7758003, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-8622061, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-9241661, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-9331082, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-9816047, http://linkedlifedata.com/resource/pubmed/commentcorrection/11167666-9849408
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0306-5251
pubmed:author
pubmed:issnType
Print
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
61-70
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy.
pubmed:affiliation
Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. APAHU@SLZ.NL
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't